Sushil K Mahata
Works at
Va San Diego Healthcare System
Professor of medicine
Sources: reporter.nih.gov
Grants and prizes
I21, Catestatin and its mimetic pharmacophore TKO-10-18 as potential therapies for age-associated muscle loss and the consequent frailty, I21RX004398, 2023–2025, 23 Oct 2024
R21, Chromogranin A is an aging risk factor, R21AG078635, 2023–2026, 2 Feb 2024
R21, Peptide therapy for age-associated gut dysmotility, R21AG080246, 2022–2025, 16 Nov 2023
Sources: reporter.nih.gov